Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$0.24 - $0.58 $5,243 - $12,672
-21,849 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$0.4 - $0.72 $8,739 - $15,731
21,849 New
21,849 $12,000
Q3 2021

Nov 15, 2021

SELL
$1.22 - $2.0 $14,194 - $23,270
-11,635 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$1.35 - $3.36 $8,202 - $20,415
6,076 Added 109.3%
11,635 $23,000
Q1 2021

May 12, 2021

SELL
$3.02 - $4.54 $1,220 - $1,834
-404 Reduced 6.78%
5,559 $18,000
Q4 2020

Feb 11, 2021

BUY
$2.42 - $4.48 $14,430 - $26,714
5,963 New
5,963 $24,000
Q3 2020

Nov 12, 2020

SELL
$2.53 - $3.4 $19,230 - $25,843
-7,601 Closed
0 $0
Q2 2020

Jul 31, 2020

SELL
$1.56 - $3.65 $10,982 - $25,696
-7,040 Reduced 48.08%
7,601 $23,000
Q1 2020

May 01, 2020

SELL
$1.96 - $7.96 $35,881 - $145,723
-18,307 Reduced 55.56%
14,641 $29,000
Q4 2019

Feb 14, 2020

BUY
$3.19 - $7.56 $61,321 - $145,325
19,223 Added 140.06%
32,948 $243,000
Q3 2019

Nov 14, 2019

BUY
$4.37 - $9.91 $59,978 - $136,014
13,725 New
13,725 $62,000
Q1 2019

May 14, 2019

SELL
$10.45 - $13.94 $13,365 - $17,829
-1,279 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$10.43 - $17.39 $51,576 - $85,993
-4,945 Reduced 79.45%
1,279 $15,000
Q3 2018

Nov 14, 2018

BUY
$11.95 - $19.63 $44,418 - $72,964
3,717 Added 148.26%
6,224 $106,000
Q2 2018

Aug 14, 2018

BUY
$8.75 - $23.27 $21,936 - $58,337
2,507 New
2,507 $43,000

About Eloxx Pharmaceuticals, Inc.


  • Ticker ELOX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,656,200
  • Description
  • Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...
More about ELOX
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.